A $500,000 ASX share portfolio could provide a very attractive passive income stream.

But the amount investors receive each year can vary significantly depending on the dividend yield they target and the types of shares they own.

A portfolio built around lower-yielding growth shares may produce less income today, while a higher-yielding portfolio may come with extra risks if the payouts are stretched.

That is why I think investors need to look beyond the headline yield and think carefully about the balance between income, quality, and growth.

So, how much could a $500,000 ASX share portfolio realistically pay in dividends?

Understanding the yield

A dividend yield shows how much income a share or portfolio pays each year compared with its value.

For an ASX dividend portfolio, the yield investors target can make a big difference to the income they receive. It can also change the type of shares they end up owning.

A 4% yield may sound modest, but it could come from businesses with stronger balance sheets, steadier earnings, or better long-term growth prospects. A 6% yield can produce more income upfront, although it may push investors toward shares with slower growth, higher debt, or less reliable payouts.

That is why I think 5% can be a good middle ground. It is high enough to generate meaningful passive income, while still leaving room to focus on quality and diversification.

On a $500,000 portfolio, a 4% yield would generate around $20,000 a year in dividends before tax and franking credits. While at 5%, the annual income would rise to about $25,000, and at 6% it would be around $30,000.

For me, the 5% option feels like a sensible target for many income investors because it balances income today with the need to own ASX dividend shares that can keep performing over time.

What could sit in the portfolio?

I would want a mix of defensive dividend shares, property income, and businesses that can grow dividends over time.

Telstra Group Ltd (ASX: TLS) could play a useful role because connectivity is woven into daily life. Mobile data, payments, work, entertainment, and communication all rely on reliable networks.

Woolworths Group Ltd (ASX: WOW) is another defensive name to consider. Grocery demand is more stable than many discretionary categories, which can help support dividends through different economic conditions.

For property income, HomeCo Daily Needs REIT (ASX: HDN) could be attractive because its portfolio is focused on everyday-needs retail, including assets linked to supermarkets, pharmacies, and essential services.

I would also leave room for dividend growth. Universal Store Holdings Ltd (ASX: UNI) and Lovisa Holdings Ltd (ASX: LOV) are more growth-focused retail shares, so they can be more volatile. But if their earnings continue to grow, their dividends could become more valuable over time.

Why growth still counts

Ideally, a dividend portfolio should grow as the years pass.

If a $500,000 portfolio grew by 5% per annum over 10 years, while dividends were banked separately, it could increase to around $815,000.

That larger portfolio could then produce much higher income. A 4% yield on $815,000 would generate around $32,600 a year, while a 5% yield would generate around $40,750 a year.

I think that shows why capital growth can be so meaningful for passive income investors.

Foolish takeaway

A $500,000 ASX share portfolio could produce a compelling income stream if it is built carefully.

I think a 5% yield is a sensible target because it could generate about $25,000 a year today while still leaving room to focus on quality, diversification, and dividend growth.

The best dividend portfolios can pay income now and become more valuable over time. That combination is what can turn a strong ASX portfolio into a much larger passive income stream in the years ahead.

The post How much could a $500,000 ASX share portfolio pay in dividends? appeared first on The Motley Fool Australia.

More reading

• ASX consumer staples shares are quietly surging while the rest of the market stalls. Here is why.
• 10 fantastic ASX shares to buy for FY27
• 9 ASX 200 shares with reiterated buy calls this week
• 3 strong ASX passive income shares I’d buy now
• How much do I need in my superannuation to get $52,000 per year in passive income?

Motley Fool contributor Grace Alvino has positions in Lovisa. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended HomeCo Daily Needs REIT, Lovisa, and Universal Store. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The turnaround in CSL Ltd (ASX: CSL) shares has been sharp.

From the nine-year low struck on 3 June 2026, CSL has surged approximately 35% to $122.89.

The question is not whether the bounce has happened. It clearly has.

The question is what is driving it, whether those drivers are durable, and what the August FY26 result will need to show to confirm this is more than a sentiment swing.

What has driven the 35% rebound in CSL shares

The honest answer is that the recovery has been driven primarily by sector rotation and valuation recognition rather than new positive company-specific news.

Healthcare was the worst-performing sector of all eleven ASX 200 market sectors in FY26. The S&P/ASX 200 Health Care Index (ASX: XHJ) fell 39% over twelve months to hit a nine-year low on 3 June.

When a sector falls that far that fast, it tends to attract bargain-hunting institutional investors at the start of a new financial year. This is even more true when those same investors have just locked in large profits in resources and energy shares.

The underlying business has not changed materially in the six weeks since 3 June.

Management’s FY26 guidance of approximately US$15.2 billion in revenue and US$3.1 billion in NPATA on a constant currency basis remains unchanged.

The operational challenges, including US immunoglobulin supply constraints and China albumin pricing pressure, remain the same.

The case that the recovery is here to stay

At the 3 June low of approximately $91, CSL was trading at approximately 11 times forecast FY26 earnings. This was a valuation not seen in more than fifteen years for a business of this quality.

At $122.89, CSL trades at approximately 15.2 times forecast FY26 earnings, still a fraction of the 30 to 50 times multiple it commanded at its peak.

Morgans retains a buy rating with a price target of $147.59, implying upside of approximately 20% from the current price.

To support this thesis, management has also pointed to stronger Behring division revenue growth in the second half of FY26. Additionally, management expects moderately stronger-than-expected Seqirus vaccine performance.

These are all early signs that the operating recovery is beginning.

The case that it is just a temporary bounce

The more cautious reading is equally legitimate.

Eight of eighteen analysts covering CSL have a buy rating, while ten have a hold.

That split reflects the uncertainty around today’s share price.

Indeed, CSL has delivered a series of earnings disappointments over the past eighteen months. Each has been framed by management as temporary before proving more persistent than expected.

The FY26 result, due on 19 August, will be the most important test of whether the recovery has earnings support or is simply a valuation-driven sentiment swing.

If August delivers another round of guidance cuts, the 35% bounce could reverse quickly.

What the August result needs to show for CSL shares

Three things would confirm the recovery is real.

First, Behring division revenue growth in the second half of FY26 that confirms rather than falls short of management’s guidance.

Second, evidence that the immunoglobulin supply and pricing situation is moving in the right direction.

Third, confidence from the new CEO, expected to be named before the result, that the operational challenges have a visible resolution path.

If those three conditions are met on 19 August, CSL’s recovery from $91 to $122.89 will look like the early innings of something more sustained.

If they are not, investors who bought the bounce may face a difficult reassessment.

Foolish takeaway

CSL shares are up 35% since early June to $122.89, but remain down 49% over twelve months.

The recovery may be here to stay, reflecting an oversold valuation at the June lows.

It may also partly be a rotation bounce, driven by institutional new-year rebalancing rather than company-specific positive news.

The August FY26 result will separate those two explanations cleanly.

Until then, the honest answer to whether the recovery is real is: we do not yet know.

The post CSL shares are up 35% since early June. Is the recovery here to stay? appeared first on The Motley Fool Australia.

More reading

• Where could CSL shares go next? Here’s what brokers are predicting
• How to go from zero to $50,000 with ASX shares
• 3 ASX blue-chip shares that could be strong long-term value plays
• Up 36%: Can CSL shares keep rebounding?
• Which ASX 200 sectors paid the highest dividend yields in FY26?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) has been choppy and directionless for several weeks.

After the strong start to FY27 in the first week of July, the broader market has stalled around the 8,800 point level as investors weigh renewed Middle East tensions, rate uncertainty, and the approaching August reporting season.

Beneath that flat headline, however, something interesting is happening.

S&P/ASX 200 Consumer Staples (ASX: XSJ) shares are quietly surging. This sector has been one of the best-performing pockets of the ASX in recent sessions as investors rotate into defensive names ahead of earnings season volatility.

Here are three ASX consumer staples shares benefiting from this upswing.

Woolworths: resilience in a cautious consumer environment

Woolworths Group Ltd (ASX: WOW) has been one of the quiet achievers of the past month.

The company provides something most ASX shares cannot guarantee: recurring revenue regardless of economic conditions.

Australians keep buying groceries, cleaning products, and personal care items through every cycle.

This earnings visibility is what institutional investors rotate toward when uncertainty rises.

Catapult Wealth’s Blake Halligan recently assessed Woolworths’ defensive credentials, noting:

“Food retail sales were up 5.9% in the third quarter of 2026 when compared to the prior corresponding period.”

Coles Group: consistent dividends and a reporting season catalyst

Coles Group Ltd (ASX: COL) has been rising alongside Woolworths, benefiting from the same defensive rotation while adding its own catalyst.

Brokers retained a positive view on Coles this week, following a period where the supermarket’s competitive positioning had been a source of investor uncertainty.

Coles pays a consistent, partially franked dividend twice per year, giving income investors a meaningful yield alongside the stability of essential retail earnings.

The approach of August reporting season adds a specific near-term catalyst.

Coles’ FY26 full-year result will give investors the most current picture of how effectively management has navigated cost inflation, loyalty program investment, and competitive pricing pressure over the past twelve months.

Bega Cheese: the defensive with a turnaround story

Bega Cheese Ltd (ASX: BGA) is the least conventional of the three but arguably the most interesting from a value perspective.

The company is Australia’s largest branded consumer dairy company, with a portfolio that includes Bega, Vegemite, and Farmers Union brands.

Like Woolworths and Coles, Bega benefits from the essential nature of its product categories.

But unlike the supermarkets, Bega carries an additional earnings recovery story on top of the defensive characteristics.

The company has been navigating a difficult period of input cost inflation and margin compression over the past two years.

Investors are buying after the company lifted its profit outlook. This has sent shares higher from growing confidence that the earnings recovery management has been guiding toward is beginning to materialise.

The combination of an essential product portfolio, a recovering earnings trajectory, and a market environment rewarding defensives makes Bega one of the more interesting propositions in the sector right now.

Why ASX consumer staples shares are having their moment

The rotation into consumer staples reflects three specific forces converging in July 2026.

First, investors who rode materials and healthcare to strong FY26 and early FY27 gains are taking profits and redeploying into lower-volatility names.

Second, renewed Middle East escalation and its impact on oil prices is raising the spectre of further RBA rate hikes. This has historically favoured defensive sectors over rate-sensitive growth names.

Third, August reporting season is six weeks away. Investors are positioning themselves into companies with more predictable earnings outcome.

Consumer staples tick all three boxes: lower volatility, insulated from oil and rate sensitivity, and with relatively predictable earnings that reduce binary outcome risk.

Foolish takeaway for ASX consumer staples shares

Woolworths, Coles, and Bega Cheese are each different versions of the same defensive investment thesis.

The broader market is stalling. Consumer staples are moving.

For investors who want to reduce portfolio volatility heading into August reporting season while maintaining exposure to quality, income-producing businesses, the current rotation into consumer staples shares is worth paying attention to.

The post ASX consumer staples shares are quietly surging while the rest of the market stalls. Here is why. appeared first on The Motley Fool Australia.

More reading

• How much could a $500,000 ASX share portfolio pay in dividends?
• How much do I need in my superannuation to get $50k per year in passive income?
• 10 fantastic ASX shares to buy for FY27
• 9 ASX 200 shares with reiterated buy calls this week
• Which is the best buy, Coles shares or Wesfarmers shares?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.